» Articles » PMID: 33143389

Natural Compounds As Guides for the Discovery of Drugs Targeting G-Protein-Coupled Receptors

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Nov 4
PMID 33143389
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptors (GPCRs), which constitute the most populous family of the human proteome, are the target of 35-45% of approved therapeutic drugs. This review focuses on natural products (excluding peptides) that target GPCRs. Natural compounds identified so far as agonists, antagonists or allosteric modulators of GPCRs have been found in all groups of existing living beings according to Whittaker's Five Kingdom Classification, i.e., bacteria (monera), fungi, protoctists, plants and animals. Terpenoids, alkaloids and flavonoids are the most common chemical structures that target GPCRs whose endogenous ligands range from lipids to epinephrine, from molecules that activate taste receptors to molecules that activate smell receptors. Virtually all of the compounds whose formula is displayed in this review are pharmacophores with potential for drug discovery; furthermore, they are expected to help expand the number of GPCRs that can be considered as therapeutic targets.

Citing Articles

Progress in Methylxanthine Biosynthesis: Insights into Pathways and Engineering Strategies.

Jiang T, Zuo S, Liu C, Xing W, Wang P Int J Mol Sci. 2025; 26(4).

PMID: 40003976 PMC: 11855574. DOI: 10.3390/ijms26041510.


Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A Receptor.

Raich I, Lillo J, Ferreiro-Vera C, Sanchez de Medina V, Navarro G, Franco R Int J Mol Sci. 2023; 24(24).

PMID: 38139329 PMC: 10744210. DOI: 10.3390/ijms242417500.


First Potent Macrocyclic A Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences.

Tosh D, Fisher C, Salmaso V, Wan T, Campbell R, Chen E ACS Pharmacol Transl Sci. 2023; 6(9):1288-1305.

PMID: 37705595 PMC: 10496144. DOI: 10.1021/acsptsci.3c00126.


Gene regulation in activated microglia by adenosine A receptor agonists: a transcriptomics study.

Lillo A, Serrano-Marin J, Lillo J, Raich I, Navarro G, Franco R Purinergic Signal. 2023; 20(3):237-245.

PMID: 36703008 PMC: 11189369. DOI: 10.1007/s11302-022-09916-9.


Exploring GPR109A Receptor Interaction with Hippuric Acid Using MD Simulations and CD Spectroscopy.

Bhandari D, Kachhap S, Madhukar G, Adepu K, Anishkin A, Chen J Int J Mol Sci. 2022; 23(23).

PMID: 36499106 PMC: 9741133. DOI: 10.3390/ijms232314778.


References
1.
Franco R, Onatibia-Astibia A, Martinez-Pinilla E . Health benefits of methylxanthines in cacao and chocolate. Nutrients. 2013; 5(10):4159-73. PMC: 3820066. DOI: 10.3390/nu5104159. View

2.
KEELER R . Teratogenic compounds of Veratrum californicum (Durand) X. Cyclopia in rabbits produced by cyclopamine. Teratology. 1970; 3(2):175-80. DOI: 10.1002/tera.1420030210. View

3.
Navarro G, Borroto-Escuela D, Fuxe K, Franco R . Purinergic signaling in Parkinson's disease. Relevance for treatment. Neuropharmacology. 2015; 104:161-8. DOI: 10.1016/j.neuropharm.2015.07.024. View

4.
Ringvold H, Khalil R . Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders. Adv Pharmacol. 2017; 78:203-301. PMC: 5319769. DOI: 10.1016/bs.apha.2016.06.002. View

5.
Mizuno Y, Kondo T . Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease. Mov Disord. 2013; 28(8):1138-41. PMC: 3842830. DOI: 10.1002/mds.25418. View